“Nucleic Acid Therapeutics and Rare Diseases”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya Smale



Michael French of Marina Biotech  joined us for World Orphan Drug Congress USA 2015 to present about ‘Nucleic Acid Therapeutics and Rare Diseases’ 
Download the presentation now  to understand more about:

  • Novel & proprietary chemistries
  • Novel & proprietary delivery systems
  • Clinical program pipeline
  •  Nucleic acid-based strategies for therapeutic intervention in DM1
…and much more!
Get your copy here!
To find out more about how  nucleic acid therapeutics can help to treat rare diseases , join us at  World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.